Modulation of circulating biomarkers in NSCLC patients correlate with stage

Autor:	L. W. Miller, Peter J. Hamer, S. P. Bradley, Walter P. Carney
Rok vydání:	2010
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Stage iv disease medicine.disease respiratory tract diseases Circulating biomarkers Internal medicine medicine Stage (cooking) business Lung cancer
Zdroj:	Journal of Clinical Oncology. 28:e21093-e21093
ISSN:	1527-7755 0732-183X
Popis:	e21093 Background: NSCLC accounts for ∼80% of all lung cancer cases. Five-year survival rates for stage IV disease are very poor compared with stage I (2% vs. 56%). Therefore, tools are needed to a...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bd6f911ce46508a11ede63dd1720d391 https://doi.org/10.1200/jco.2010.28.15_suppl.e21093 Zobrazit plný text záznamu